MetLife Investment Management’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $102K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $148K | Buy |
|
|||||
|
2024
Q2 | $39.9K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $57.2K | Hold |
|
|||||
|
2023
Q2 | $80.6K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $87K | Hold |
|
|||||
|
2022
Q3 | $117K | Hold |
|
|||||
|
2022
Q2 | $185K | Hold |
|
|||||
|
2022
Q1 | $208K | Buy |
|
|||||
|
2021
Q4 | $199K | Hold |
|
|||||
|
2021
Q3 | $121K | Buy |
|